https://www.law360.com/health/articles/2461/brand-name-drug-makers-blame-patent-expirations-for-depressed-profits?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T19:06:13Z monthly 0.5 https://www.law360.com/health/articles/2464/glaxo-wins-first-battle-in-fight-against-reimportation-of-patented-drugs?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T06:04:04Z monthly 0.5 https://www.law360.com/health/articles/2453/fda-calls-for-uniform-name-for-biogenerics?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T06:00:16Z monthly 0.5 https://www.law360.com/health/articles/2450/flamel-withdraws-lawsuit-vs-novo-nordisk?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T07:24:34Z monthly 0.5 https://www.law360.com/health/articles/2448/ethypharm-sues-bentley-over-trade-secrets?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T00:21:05Z monthly 0.5 https://www.law360.com/health/articles/2446/canadian-branded-drug-makers-miss-r-d-target?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T22:04:25Z monthly 0.5 https://www.law360.com/health/articles/2433/bayer-takes-license-for-homocysteine-assay-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T06:48:08Z monthly 0.5 https://www.law360.com/health/articles/2437/swiss-activists-form-coalition-to-oppose-proposed-patent-law-revisions?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T18:10:53Z monthly 0.5 https://www.law360.com/health/articles/2436/india-government-unveils-details-of-patent-regime-overhaul?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T10:36:21Z monthly 0.5 https://www.law360.com/health/articles/2419/genentech-loses-appeal-of-500m-royalties-verdict?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T15:40:13Z monthly 0.5 https://www.law360.com/health/articles/2417/enzo-expected-to-net-hundreds-of-millions-in-royalties-from-digene-settlement?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T04:12:22Z monthly 0.5 https://www.law360.com/health/articles/2418/u-s-constitution-bars-canadian-drug-imports-research-paper-argues?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T11:41:21Z monthly 0.5 https://www.law360.com/health/articles/2408/u-k-house-of-lords-declares-amgen-s-erythropoietin-patent-invalid?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T14:19:57Z monthly 0.5 https://www.law360.com/health/articles/2409/akzo-nobel-to-pay-36m-in-third-settlement-over-remeron-patent-evergreening?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T13:37:04Z monthly 0.5 https://www.law360.com/health/articles/2394/bausch-lomb-unit-sued-over-patent-for-vitrectomy-cutter?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T13:29:15Z monthly 0.5 https://www.law360.com/health/articles/2385/india-to-overhaul-patent-regime-during-parliament-s-winter-session?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T06:48:07Z monthly 0.5 https://www.law360.com/health/articles/2389/afl-cio-sues-astrazeneca-over-handling-of-prilosec-patent-expiration?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T10:56:43Z monthly 0.5 https://www.law360.com/health/articles/2384/u-s-israeli-negotiators-make-progress-in-talks-on-drug-ip-rights?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T07:24:33Z monthly 0.5 https://www.law360.com/health/articles/2374/j-j-unit-sues-st-jude-medical-unit-over-medical-device-patents?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T18:38:18Z monthly 0.5 https://www.law360.com/health/articles/2375/judge-rules-tkt-infringes-amgen-erythropoietin-patents?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T20:31:32Z monthly 0.5 https://www.law360.com/health/articles/2368/digene-agrees-to-pay-16m-plus-royalties-to-settle-enzo-biochem-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T13:03:13Z monthly 0.5 https://www.law360.com/health/articles/2369/israel-provoking-global-drug-patent-dispute-e-u-warns?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T01:26:41Z monthly 0.5 https://www.law360.com/health/articles/2371/doctors-who-stole-patient-lists-misappropriated-trade-secrets-judge-rules?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T23:01:59Z monthly 0.5 https://www.law360.com/health/articles/2372/artes-medical-asks-epo-uspto-to-revoke-patents-for-sanofi-aventis-lipoatrophy-treatment?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T19:56:49Z monthly 0.5 https://www.law360.com/health/articles/2363/judge-enters-permanent-injunction-vs-medtronic-units-in-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T15:40:12Z monthly 0.5 https://www.law360.com/health/articles/2358/judge-clears-alpharma-s-generic-neurontin?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T04:05:47Z monthly 0.5 https://www.law360.com/health/articles/2355/jury-orders-medtronic-unit-to-pay-400m-in-punitive-damages-in-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T11:45:59Z monthly 0.5 https://www.law360.com/health/articles/2351/u-s-israeli-officials-to-tackle-dispute-over-drug-data-exclusivity?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T09:04:36Z monthly 0.5 https://www.law360.com/health/articles/2348/tyco-healthcare-unit-sues-j-j-unit-over-surgical-scalpel-patents?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T23:05:10Z monthly 0.5 https://www.law360.com/health/articles/2346/hatch-eyes-generic-biologics-bill-modeled-on-e-u-approach?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T12:39:29Z monthly 0.5 https://www.law360.com/health/articles/2339/in-risky-move-alpharma-launches-generic-neurontin?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T11:02:18Z monthly 0.5 https://www.law360.com/health/articles/2347/hatch-waxman-signal-concern-about-authorized-generics-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T11:04:55Z monthly 0.5 https://www.law360.com/health/articles/2338/hearing-on-neurontin-injunction-closes-without-ruling?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T21:55:21Z monthly 0.5 https://www.law360.com/health/articles/2325/pfizer-sues-poland-s-top-drug-maker-over-viagra-knockoff?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T13:58:26Z monthly 0.5 https://www.law360.com/health/articles/2323/bausch-lomb-sues-ocular-sciences-over-contact-lens-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T12:43:29Z monthly 0.5 https://www.law360.com/health/articles/2319/u-s-supreme-court-mulls-rare-review-of-patent-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T17:48:07Z monthly 0.5 https://www.law360.com/health/articles/2317/astrazeneca-loses-battle-against-generic-plendil-at-federal-circuit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T18:34:40Z monthly 0.5 https://www.law360.com/health/articles/2306/collagenix-sues-over-andas-for-periostat-generics?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T10:36:20Z monthly 0.5 https://www.law360.com/health/articles/2307/merck-sues-dr-reddy-s-over-anda-for-propecia-generic?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T00:23:10Z monthly 0.5 https://www.law360.com/health/articles/2311/akzo-nobel-settles-antitrust-litigation-over-remeron-patents-for-59-8m?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T20:41:41Z monthly 0.5 https://www.law360.com/health/articles/2299/glaxo-faces-another-antitrust-suit-over-relafen-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T19:29:50Z monthly 0.5